Perrigo Company plc 0Y5E.L
0Y5E.L
Perrigo Company plc 0VQA.L
Viking Therapeutics, Inc. 0HF9.L
Amicus Therapeutics, Inc. 0EE0.L
uniQure N.V. 0HB0.L
Agios Pharmaceuticals, Inc. 0UNL.L
Nektar Therapeutics 0L35.L
Sarepta Therapeutics, Inc. 0JBU.L
Intellia Therapeutics, Inc. 0LOV.L
Verastem, Inc. 0LB2.L
Supernus Pharmaceuticals, Inc.
Perrigo Company plc 0VQA.L
Viking Therapeutics, Inc. 0HF9.L
Amicus Therapeutics, Inc. 0EE0.L
uniQure N.V. 0HB0.L
Agios Pharmaceuticals, Inc. 0UNL.L
Nektar Therapeutics 0L35.L
Sarepta Therapeutics, Inc. 0JBU.L
Intellia Therapeutics, Inc. 0LOV.L
Verastem, Inc. 0LB2.L
Supernus Pharmaceuticals, Inc.
Performance
| Periode | 0Y5E.L | 0VQA.L | 0HF9.L | 0EE0.L | 0HB0.L | 0UNL.L | 0L35.L | 0JBU.L | 0LOV.L | 0LB2.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -12.81 % | 40.96 % | 21.04 % | 364.84 % | 47.27 % | 157.16 % | -61.66 % | 78.06 % | 8.76 % | 66.18 % |
| YTD | -16.74 % | -14.60 % | -5.84 % | 264.36 % | 30.59 % | 6 148.74 % | -81.42 % | 20.08 % | 38.80 % | 46.51 % |
| 1Y | -14.52 % | -53.55 % | -23.55 % | 867.01 % | -5.51 % | 4 521.29 % | -82.03 % | -11.14 % | 149.77 % | 54.59 % |
| 3Y | -34.39 % | 714.27 % | -15.86 % | 250.66 % | 51.80 % | 1 536.09 % | -79.13 % | -72.58 % | 98.89 % | 53.39 % |
| 5Y | -34.39 % | 462.48 % | -7.13 % | 54.80 % | 27.96 % | 314.26 % | -69.75 % | -84.90 % | -71.13 % | 143.19 % |
| 10Y | -34.39 % | 139.70 % | -7.13 % | 241.62 % | -45.85 % | 314.26 % | -69.75 % | -84.90 % | -78.94 % | 28.37 % |
| From the beginning | -34.39 % | 139.70 % | -7.13 % | 241.62 % | -45.85 % | 314.26 % | -69.75 % | -84.90 % | -78.94 % | 28.37 % |